CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 40 filers reported holding CTI BIOPHARMA CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,805,255 | -1.4% | 906,013 | +41.1% | 0.00% | 0.0% |
| Q4 2022 | $3,859,147 | -33.0% | 642,121 | -35.1% | 0.00% | -25.0% |
| Q3 2022 | $5,759,000 | +118.3% | 989,446 | +123.9% | 0.00% | +100.0% |
| Q2 2022 | $2,638,000 | +585.2% | 441,843 | +436.1% | 0.00% | – |
| Q1 2022 | $385,000 | – | 82,418 | +2747166.7% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 3 | -100.0% | 0.00% | – |
| Q1 2021 | $77,000 | -1.3% | 26,563 | +10.0% | 0.00% | – |
| Q4 2020 | $78,000 | – | 24,144 | +804700.0% | 0.00% | – |
| Q3 2020 | $0 | – | 3 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 3 | -87.0% | 0.00% | – |
| Q1 2020 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 23 | -99.6% | 0.00% | – |
| Q3 2019 | $5,000 | -28.6% | 5,784 | -25.2% | 0.00% | – |
| Q2 2019 | $7,000 | -50.0% | 7,734 | -44.2% | 0.00% | – |
| Q1 2019 | $14,000 | +40.0% | 13,870 | +2.2% | 0.00% | – |
| Q4 2018 | $10,000 | -69.7% | 13,578 | -12.0% | 0.00% | – |
| Q3 2018 | $33,000 | -13.2% | 15,426 | +106.6% | 0.00% | – |
| Q2 2018 | $38,000 | – | 7,465 | +5824.6% | 0.00% | – |
| Q1 2018 | $0 | – | 126 | +18.9% | 0.00% | – |
| Q4 2017 | $0 | – | 106 | -15.9% | 0.00% | – |
| Q3 2017 | $0 | – | 126 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 126 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|